Despite the potential use of TRAIL as a chemotherapeutic target, recent reports show the emergence of resistance of pancreatic cancer cells to TRAIL-induced apoptosis (James and Griffith, 2014). Here, TNFSF10 is linked to familial pancreatic carcinoma.